Idioma:

The effect of extracellular matrix on the precision medicine utility of pancreatic cancer patient-derived organoids

Lumibao, Jan C ; Okhovat, Shira R ; Peck, Kristina L ; Lin, Xiaoxue ; Lande, Kathryn ; Yomtoubian, Shira ; Ng, Isabella ; Tiriac, Hervé ; Lowy, Andrew M ; Zou, Jingjing ; Engle, Dannielle D

JCI insight, 2024-01, Vol.9 (1) [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por

Enviar para

Título:
The effect of extracellular matrix on the precision medicine utility of pancreatic cancer patient-derived organoids
Autor: Lumibao, Jan C ; Okhovat, Shira R ; Peck, Kristina L ; Lin, Xiaoxue ; Lande, Kathryn ; Yomtoubian, Shira ; Ng, Isabella ; Tiriac, Hervé ; Lowy, Andrew M ; Zou, Jingjing ; Engle, Dannielle D
Assuntos: Animals ; Carcinoma, Pancreatic Ductal - drug therapy ; Carcinoma, Pancreatic Ductal - genetics ; Carcinoma, Pancreatic Ductal - metabolism ; Extracellular Matrix ; Humans ; Mice ; Organoids - metabolism ; Pancreatic Neoplasms - drug therapy ; Pancreatic Neoplasms - genetics ; Pancreatic Neoplasms - metabolism ; Precision Medicine
É parte de: JCI insight, 2024-01, Vol.9 (1)
Notas: ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Descrição: The use of patient-derived organoids (PDOs) to characterize therapeutic sensitivity and resistance is a promising precision medicine approach, and its potential to inform clinical decisions is now being tested in several large multiinstitutional clinical trials. PDOs are cultivated in the extracellular matrix from basement membrane extracts (BMEs) that are most commonly acquired commercially. Each clinical site utilizes distinct BME lots and may be restricted due to the availability of commercial BME sources. However, the effect of different sources of BMEs on organoid drug response is unknown. Here, we tested the effect of BME source on proliferation, drug response, and gene expression in mouse and human pancreatic ductal adenocarcinoma (PDA) organoids. Both human and mouse organoids displayed increased proliferation in Matrigel compared with Cultrex and UltiMatrix. However, we observed no substantial effect on drug response when organoids were cultured in Matrigel, Cultrex, or UltiMatrix. We also did not observe major shifts in gene expression across the different BME sources, and PDOs maintained their classical or basal-like designation. Overall, we found that the BME source (Matrigel, Cultrex, UltiMatrix) does not shift PDO dose-response curves or drug testing results, indicating that PDO pharmacotyping is a robust approach for precision medicine.
Editor: United States
Idioma: Inglês

Links

View this record in MEDLINE/PubMed

Voltar para lista de resultados

Realização: Logos de Redes Sociais:

The effect of extracellular matrix on the precision medicine utility of pancreatic cancer patient-derived organoids

Lumibao, Jan C ; Okhovat, Shira R ; Peck, Kristina L ; Lin, Xiaoxue ; Lande, Kathryn ; Yomtoubian, Shira ; Ng, Isabella ; Tiriac, Hervé ; Lowy, Andrew M ; Zou, Jingjing ; Engle, Dannielle D

United States

Buscando em bases de dados remotas. Favor aguardar.